European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)

Launched by the European Medicines Agency (EMEA), the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) project is aimed at strengthening the monitoring of post-marketed medical products in Europe. The project’s goals include facilitating multi-center, independent, PASS and studies focusing on a lack of efficacy.

Completed in early 2009, the first phase of ENCePP was to identify experienced pharmacoepidemiology and pharmacovigilance research centers across Europe. Outcome Europe, along with 84 other newly identified research centers, will serve as a major resource for enabling the commission and implementation of PASS, by healthcare stakeholders, such as the life sciences industry or regulatory agencies, that may provide further insight into the benefit-risk balance of marketed products in Europe.

Visit the ENCepp website to learn more about the project or contact Outcome Europe at info@outcome.com or +800 688 266 37.

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We recommend to our sponsors to register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.